Mark Ashby - Concepedia

Author

Mark Ashby

St Vincent's Hospital Sydney

Also Known As

Ashby, M., Ashby, Mark, M A Ashby, M Ashby, M. ASHBY, M. Ashby, M.A. Ashby, Mark A Ashby, Mark A. Ashby, Mark Ashby

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

St Vincent's Hospital Sydney University of California, Los Angeles Saint Vincent's Catholic Medical Center City Of Hope National Medical Center The University of Texas MD Anderson Cancer Center

About

Mark Ashby is an author at St Vincent's Hospital Sydney specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	1.1K
2	Education	3	3	165
3	Allergy	2	2	200
4	Health Sciences	1	1	10
5	Social Sciences	1	1	75

Mark Ashby

Publications

Citations

H-Index

Page 1

	Year	Citations
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience Andrew D. Seidman, Clifford A. Hudis, Mary Kathryn Pierri, Journal of Clinical Oncology	2002	1.5K
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy Allen P. Kaplan, Dennis K. Ledford, Mark Ashby, Journal of Allergy and Clinical Immunology Symptomatic ChronicAllergy MedicineClinical DermatologyStandard Combination TherapyDermatology	2013	552
Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study Mark Kozloff, Marianne Ulcickas Yood, Jordan Berlin, The Oncologist	2009	307
Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer Saroj Vadhan‐Raj, Claire F. Verschraegen, Carlos Bueso-Ramos, Annals of Internal Medicine	2000	191
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma Jonathan Corren, Thomas B. Casale, Yamo Deniz, Journal of Allergy and Clinical Immunology AsthmaAllergyAllergy MedicineImmunologyAllergen	2003	188
Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort Study Mark Kozloff, Jordan Berlin, Patrick J. Flynn, Oncology	2010	125
A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation Steven H. Bernstein, Auayporn Nademanee, Julie M. Vose, Blood	1998	115
A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation Steven H. Bernstein, Auayporn Nademanee, Julie M. Vose, Blood	1998	110
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation Richard A. Nash, Razelle Kurzrock, John F. DiPersio, Biology of Blood and Marrow Transplantation	2000	85
Recombinant Human Thrombopoietin in Combination With Granulocyte Colony-Stimulating Factor Enhances Mobilization of Peripheral Blood Progenitor Cells, Increases Peripheral Blood Platelet Concentration, and Accelerates Hematopoietic Recovery Following High-Dose Chemotherapy George Somlo, Irena Sniecinski, Anna ter Veer, Blood	1999	85

Page 1